Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Celldex Therapeutics, Inc. (CLDX)

Add CLDX Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 7/16/2017 11:07:15 AM - Followers: 97 - Board type: Free - Posts Today: 0



 Celldex Therapeutics, Inc. (CLDX)





Company Information:
Celldex Therapeutics, Inc.
222 Cameron Drive
Suite 400
Phillipsburg, NJ. 08865
Phone: 908-454-7120
Fax:  908-454-1911
Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company’s pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers—including many underserved or completely un-served orphan indications. This has created a leading pipeline in immunotherapy comprised of two candidates in pivotal trials, one in brain cancer and one in triple negative breast cancer, four additional clinical candidates in a range of difficult-to-treat indications and a robust preclinical engine.
Many of our clinical programs seek to leverage the power of the immune system’s response by combining therapeutic approaches to maximize their potential. Key to this strategy is our ability to understand our own asset base while also identifying promising external technologies that will complement it. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex (now a subsidiary of the Bristol-Myers Squibb Company) and, in connection with this transaction, Celldex retains the rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform. Since its inception, Celldex has also acquired four companies, folding in three assets, and in-licensed/purchased an additional two assets. With the potential for positive results in ongoing late stage programs, the next stage in Celldex’s development is to become a fully-integrated commercial entity.
Product Pipeline:
News and Press Releases:


November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes
Events and Presentations:
SEC Filings:
Transfer Agent:
Computershare, Inc.
250 Royall Street
Canton, MA 02021
Phone: (US) 800-736-3001 / (Int’l) 781-575-2000
Share Structure:
See SEC filings
Investor Relations:
Sarah Cavanaugh
Vice President
Investor Relations & Corporate Communications


November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes

yes November 8, 2016  yes

From a financial standpoint, the biggest update from Celldex related to its cash position. The biotech reported cash, cash equivalents, and marketable securities totaling $203.2 million at the end of the third quarter. Celldex used $24 million in cash during the quarter. 







All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.


Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.


Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CLDX News: Initial Statement of Beneficial Ownership (3) 07/05/2017 05:56:42 PM
CLDX News: Statement of Changes in Beneficial Ownership (4) 07/05/2017 04:35:54 PM
CLDX News: Current Report Filing (8-k) 07/05/2017 04:03:10 PM
CLDX News: Statement of Changes in Beneficial Ownership (4) 06/16/2017 09:33:27 AM
CLDX News: Statement of Changes in Beneficial Ownership (4) 06/16/2017 09:33:27 AM
#1419   I think I may be flipping some and 2014shelby 06/25/17 12:14:10 PM
#1418   Yeah, $4 would be good at this point trebeg 06/25/17 12:10:25 PM
#1417   Good point. How about just $4 first? CLDX 2014shelby 06/23/17 09:35:41 PM
#1416   Harry...I would love to see your scenario play trebeg 06/23/17 06:49:52 PM
#1415   all the insiders are buying up shares as harry crumb 06/22/17 11:54:46 PM
#1414   Will CLDX ever hit $4 again? 2014shelby 06/22/17 06:46:16 PM
#1413   there will be massive covering coming if their harry crumb 06/21/17 10:24:55 AM
#1412   liking the new trend its forming. good chance harry crumb 06/19/17 09:25:35 PM
#1411   added more, go cldx! harry crumb 06/16/17 02:01:39 PM
#1410   back up, timing is everything. hopefully they got harry crumb 06/08/17 01:01:22 PM
#1409   Geeez, where's the bottom. Bought some @ 2.38 Hard Locke1 06/07/17 03:46:14 PM
#1408   covered boxed short position, let it go up harry crumb 06/07/17 08:41:09 AM
#1407   This was like $30 at one time. Hope noretreat 06/06/17 07:46:05 PM
#1406   That failure in glio trial did CLDX no north40000 06/06/17 06:39:54 PM
#1405   lets hope they nail the science, this was harry crumb 06/06/17 04:22:23 PM
#1404   Buying shares and never letting go. When this REDEMPTIVE 06/06/17 02:37:09 PM
#1403   adding shares here on the dip, they are harry crumb 06/06/17 12:49:21 PM
#1402   What we have here is a typical sell REDEMPTIVE 06/06/17 11:40:34 AM
#1401   New 52 week lows....painful to watch. Locke1 06/06/17 11:07:13 AM
#1400   Thanks for your opinion, I tend to agree. Locke1 06/06/17 06:21:23 AM
#1399   Locke1, I don't see a mistake here as trebeg 06/06/17 02:56:10 AM
#1398   It seems latest information given was not well Locke1 06/05/17 10:44:43 PM
#1397   mayb, hearing theres excitement coming harry crumb 06/01/17 10:03:56 AM
#1396   Im in at 2.83, hoping we get a ConstitutionNow 05/31/17 10:56:49 PM
#1395   sector harry crumb 05/31/17 02:56:57 PM
#1394   Not looking that way today?? What's driving it REDEMPTIVE 05/31/17 10:38:35 AM
#1393   going to get interesting here with cldx with harry crumb 05/28/17 08:41:30 AM
#1392   we are buyers! harry crumb 05/10/17 12:03:28 PM
#1391   Where's the bottom here Harry? Serious question. dropped cdaniel394 05/10/17 11:36:49 AM
#1390   "Financial guidance: Celldex believes that the cash, cash rayank 05/10/17 08:03:02 AM
#1389   Nice write up on 4/1/17 - rayank 04/03/17 01:21:39 PM
#1388   Thanks for the heads up as always! Got erehdogmai 03/30/17 09:35:22 AM
#1387   * * $CLDX Video Chart 03-29-17 * * ClayTrader 03/29/17 05:28:00 PM
#1386   Very nice. rayank 03/29/17 04:10:09 PM
#1385   Nice ride today. Most excitement we've seen in erehdogmai 03/29/17 01:07:31 PM
#1384   absolutely, been adding lots of cldx from these prices harry crumb 03/27/17 06:30:54 PM
#1383   Hi all, I'm new in this today. rayank 03/22/17 11:57:34 AM
#1382   I'm not Harry, however the upcoming Catalyst over Hypocrates 03/07/17 03:56:52 PM
#1381   Do you think is a buy yet Harry? cdaniel394 03/07/17 01:19:31 PM
#1380   Yikes, I guess the presentation today must have disappointed. Hypocrates 03/07/17 10:40:20 AM
#1379   Interesting movement the last several days. Great opportunities here. erehdogmai 03/06/17 02:42:35 PM
#1378   upcoming catalysts hopefully bring good news, everyone seems harry crumb 02/28/17 05:11:45 PM
#1377   Good to see you here Harry, what make REDEMPTIVE 02/26/17 11:48:41 AM
#1376   interesting things happening with cldx. looking good here harry crumb 02/24/17 02:16:32 AM
#1375   So what's going on ? 8k? Joeymc77 02/07/17 09:52:41 PM
#1374   So are you buying here at $3.61? Looks stockboy 01/04/17 05:20:59 AM
#1373   if good news comes out i agree, until harry crumb 12/13/16 12:12:40 PM
#1372   Seriously over sold! Shorts have been giving up REDEMPTIVE 12/12/16 01:27:13 PM
#1371   pipeline is extremely undervalued here by pps, very harry crumb 12/11/16 08:53:19 AM
#1370   Let's not forget CDX-011 this could be a REDEMPTIVE 11/23/16 11:56:49 AM